돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1373714생성일: 2026년 10월 25일

1-Methylhomopiperazine → 2-[4-(4-Methylhexahydro-1,4-diazepin-1-yl)piperidin-1-ylcarbonyl]amino-N-(5-chloropyridin-2-yl)benzamide

https://huagongshe.com/reaction/1373714

반응식

참여 물질

역할이름HCID투입량
반응물1-MethylhomopiperazineHCID 228349—
반응물Sodium cyanoborohydrideHCID 5003444—
반응물N-(5-Chloropyridin-2-yl)-2-(4-oxopiperidin-1-ylcarbonyl)aminobenzamideHCID 21906655—
용매Acetic AcidHCID 176—
용매MethanolHCID 887—
생성물2-[4-(4-Methylhexahydro-1,4-diazepin-1-yl)piperidin-1-ylcarbonyl]amino-N-(5-chloropyridin-2-yl)benzamideHCID 21075306—

반응 단계

A solution of N-(5-chloropyridin-2-yl)-2-(4-oxo-piperidin-1-ylcarbonyl)aminobenzamide (100 mg, 0.268 mmol) and 4-methyl(hexahydro-1,4-diazepine) (0.03 mL, 0.241 mmol) in 10% acetic acid in methanol (2.2 mL) was treated with sodium cyanoborohydride (20 mg, 0.268 mmol). After 15 h, the mixture was loaded onto a SCX column, which was pretreated with a solution of 5% acetic acid in methanol. The column was eluted with methanol followed by 2 N ammonia in methanol. The eluent was concentrated to afford title compound.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07163938B2
출처 데이터셋uspto-grants-2007_01
ORD IDord-f11a75d437d447ea94c534a460c374b2
출처 메모uspto-grants-2007_01